Cochlear Implant Recipients: Comprehensive Longitudinal Evaluation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorEye & ENT Hospital of Fudan University
About this trial
This study aims to assess hearing and speech perception, as well as quality of life, in deaf patients of all ages before and after cochlear implantation, and to explore differences across age groups and treatment subtypes, thereby providing evidence for personalized hearing and speech rehabilitation.
Eligibility criteria
Qualifiers
Patients with severe or greater hearing loss (≥65 dB) scheduled to receive cochlear implant (CI) treatment.
No restrictions on age or gender.
Native language is Mandarin Chinese.
The subject and/or their legal guardian must provide informed consent prior to the study, voluntarily sign a written informed consent form, and be willing to undergo follow-up assessments at the specified time points.
Disqualifiers
Presence of other severe diseases unsuitable for cochlear implantation surgery.
Significant psychological problems or mood disorders (e.g., notable anxiety, depression, or behavioral disorders) that would preclude cooperation with training and follow-up.
Neurological diseases (e.g., epilepsy, cerebral palsy) that may affect auditory processing ability.
Concurrent participation in other interventional studies involving drugs or behavioral interventions that may affect auditory rehabilitation during the study period.
Trial design
Treatments tested in this trial
- Cochlear Implantation
Treatment groups
300 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov